This is accomplished by binding specific antibodies that bind to receptors expressed on the tumor cell such as attaching anti-Her2/neu antibody to the nanosystem, which binds to Her2/neu receptors on the tumor cell membrane. The gene discussed is ERBB2; the disease is neoplasm.